ENVB Enveric Biosciences, Inc. Quarterly EPS earnings growth

Official company branding of Enveric Biosciences, Inc. (ENVB)

Enveric Biosciences (ENVB) is developing the Psybrary AI platform for the synthesis of psilocybin-based molecules with the goal of licensing patents. The percentage change in quarterly EPS visualizes current volatility, where 93.60 reflects the latest value of the metric. The absence of commercial products creates financial stagnation until the sales stage. Meanwhile, Enveric Biosciences (ENVB) adheres to ESG standards by implementing energy-efficient solutions in the development of cannabinoid drugs.

Enveric Biosciences Inc (ENVB) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/14/2026

Analytical breakdowns for Enveric Biosciences

- market value and analyst target forecast:
Price Chart Enveric Biosciences, Inc.|ENVB - Consensus Target
- market capitalization data:
Market Capitalization Enveric|ENVB - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Enveric Biosciences|ENVB - Accounting Capitalization|Market Cap to Net Assets Ratio enveric.com|ENVB - Aggregate Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Enveric Biosciences|ENVB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Enveric Biosciences|ENVB - Aggregate Debt Obligations|Debts to Book Capitalization Enveric|ENVB - Long-Term Debt Volume|Company Short-Term Debts Enveric Biosciences|Quick Liquidity Indicator enveric.com
- earnings and market multiples details:
ENVB - Final Profit|Projected Future Earnings Enveric Biosciences|ENVB - Price to Earnings Ratio|Forward P/E Multiple Enveric|ENVB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Enveric|ENVB - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Enveric Biosciences|ENVB - Net earnings per share for the last four quarters|Quarterly EPS earnings growth enveric.com|ENVB - Net earnings per share growth this year|Earnings growth forecast for next year Enveric Biosciences
- company sales and revenue statistics:
ENVB - Company Gross Revenue|Projected Sales Volume Enveric Biosciences, Inc.|ENVB - Price to Sales|Price-to-Projected Revenue Ratio Enveric
Summary company analytics:Enveric Biosciences, Inc. - ENVB
Flagship merchandise of Enveric Biosciences

This indicator measures the quarterly dynamics of net earnings per share, allowing investors to assess the rate of capital depletion or the pace of yield recovery. By analyzing the quarterly EPS growth trend on the GURU.Markets platform, one can determine how effectively the delegation of research to CRO centers, while Enveric Biosciences (ENVB) retains its patents, impacts financial stability and the ultimate investment attractiveness of the asset.

Competitors of Enveric Biosciences (ENVB)

Indivior (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharma|CRON (Cronos) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Canopy Growth Corp. CGC|Year-over-year earnings per share growth for the last twelve months High Tide Inc. (HITI)|auroramj.com - Year-over-year earnings per share growth for the last 12 months|Achieve Life Sciences, Inc. - Year-over-year net earnings per share growth for the last 12 months|skyebioscience.com - Year-over-year earnings per share growth for the last twelve months|Anebulo - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months InterCure Ltd.|nutriband.com (NTRB) - Year-over-year earnings per share growth for the last twelve months|Nasus Pharma - Year-over-year earnings per one share growth for the last 12 months|IGC (India Globalization Capital) - Quarterly EPS earnings growth|MIRA Pharma (MIRA) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth FLGC|Year-over-year net earnings per share growth for the last 12 months imcannabis.com IMCC|Adial Pharmaceuticals, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ARTL|Ensysce - Quarterly EPS earnings growth|TTNP: Year-over-year earnings per share growth for the last twelve months|GNLN: Quarterly EPS earnings growth|INM - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Akanda|Earnings per share growth in annualized terms for the last twelve months Bright Green Corp BGXX|Year-over-year earnings per share growth for the last twelve months Hempacco (HPCO)